REVERSIBILITY OF THE INTERACTION OF CGP-11305-A WITH MAO-A INVIVO

[1] MONOAMINE OXIDASE-B INHIBITOR DEPRENYL POTENTIATES PHENYLETHYLAMINE BEHAVIOR IN RATS WITHOUT INHIBITION OF CATECHOLAMINE METABOLITE FORMATION [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1975, 34 (01) : 181 - 187

[2] THE NATURE OF THE INHIBITION OF RAT-LIVER MONOAMINE-OXIDASE TYPE-A AND TYPE-B BY THE ACETYLENIC INHIBITORS CLORGYLINE, L-DEPRENYL AND PARGYLINE [J]. BIOCHEMICAL PHARMACOLOGY, 1982, 31 (22) : 3555 - 3561

[3] A NEW APPROACH TO THE ASSESSMENT OF THE POTENCY OF REVERSIBLE MONOAMINE-OXIDASE INHIBITORS INVIVO, AND ITS APPLICATION TO (+)-AMPHETAMINE, PARA-METHOXYAMPHETAMINE AND HARMALINE [J]. BIOCHEMICAL PHARMACOLOGY, 1980, 29 (20) : 2781 - 2789

[4] METHOD FOR ASSAY OF CONJUGATED 3,4-DIHYDROXYPHENYLGLYCOL, A MAJOR NORADRENALINE METABOLITE IN RAT-BRAIN [J]. JOURNAL OF NEUROCHEMISTRY, 1976, 27 (05) : 1211 - 1217

[5] TOZER TN, 1966, J PHARMACOL EXP THER, V153, P177

[6] Waldmeier P.C., 1981, MONOAMINE OXIDASE IN, P87

[7] PREFERENTIAL DEAMINATION OF DOPAMINE BY AN A-TYPE MONOAMINE-OXIDASE IN RAT-BRAIN [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1976, 292 (01) : 9 - 14

[8] THE MONOAMINE-OXIDASE INHIBITING PROPERTIES OF CGP-11305-A [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 94 (1-2) : 73 - 83

[9] TURNOVER OF ACID DOPAMINE METABOLITES IN STRIATAL AND MESOLIMBIC TISSUE OF RAT-BRAIN [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1976, 37 (02) : 249 - 255

[10] A SENSITIVE AND SPECIFIC ASSAY FOR ESTIMATION OF MONOAMINE OXIDASE [J]. BIOCHEMICAL PHARMACOLOGY, 1963, 12 (12) : 1439 - &

[1] MONOAMINE OXIDASE-B INHIBITOR DEPRENYL POTENTIATES PHENYLETHYLAMINE BEHAVIOR IN RATS WITHOUT INHIBITION OF CATECHOLAMINE METABOLITE FORMATION [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1975, 34 (01) : 181 - 187

[2] THE NATURE OF THE INHIBITION OF RAT-LIVER MONOAMINE-OXIDASE TYPE-A AND TYPE-B BY THE ACETYLENIC INHIBITORS CLORGYLINE, L-DEPRENYL AND PARGYLINE [J]. BIOCHEMICAL PHARMACOLOGY, 1982, 31 (22) : 3555 - 3561

[3] A NEW APPROACH TO THE ASSESSMENT OF THE POTENCY OF REVERSIBLE MONOAMINE-OXIDASE INHIBITORS INVIVO, AND ITS APPLICATION TO (+)-AMPHETAMINE, PARA-METHOXYAMPHETAMINE AND HARMALINE [J]. BIOCHEMICAL PHARMACOLOGY, 1980, 29 (20) : 2781 - 2789

[4] METHOD FOR ASSAY OF CONJUGATED 3,4-DIHYDROXYPHENYLGLYCOL, A MAJOR NORADRENALINE METABOLITE IN RAT-BRAIN [J]. JOURNAL OF NEUROCHEMISTRY, 1976, 27 (05) : 1211 - 1217

[5] TOZER TN, 1966, J PHARMACOL EXP THER, V153, P177

[6] Waldmeier P.C., 1981, MONOAMINE OXIDASE IN, P87

[7] PREFERENTIAL DEAMINATION OF DOPAMINE BY AN A-TYPE MONOAMINE-OXIDASE IN RAT-BRAIN [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1976, 292 (01) : 9 - 14

[8] THE MONOAMINE-OXIDASE INHIBITING PROPERTIES OF CGP-11305-A [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 94 (1-2) : 73 - 83

[9] TURNOVER OF ACID DOPAMINE METABOLITES IN STRIATAL AND MESOLIMBIC TISSUE OF RAT-BRAIN [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1976, 37 (02) : 249 - 255

[10] A SENSITIVE AND SPECIFIC ASSAY FOR ESTIMATION OF MONOAMINE OXIDASE [J]. BIOCHEMICAL PHARMACOLOGY, 1963, 12 (12) : 1439 - &